Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Divy Decision

Divy Decision

posted on Feb 07, 2008 07:13AM
Has anyone given any thought to why the BOD considered another divy? It seems to me that the timing of its consideration might be telling us something. Also, had they went ahead with say a 2/3/4cent divy, how many shareholders would that help other than Swartz? And what would that say about the anticipated M&A activity? A no on the divy would seem like a no brainer. So why is it even brought up, and why the need to make it public? Opty
Share
New Message
Please login to post a reply